"Breaking the norm, the patient's lung cancer has not recurred or metastasized five years after surgery, thanks to this method."

If you find it difficult to understand the subsequent professional descriptions, you can easily grasp the essence of this text within two minutes. Mr. Li did not receive any other anti-tumor treatments after his surgery, and his treatment background is relatively straightforward, making it easy to evaluate the effectiveness of NKT cell therapy. We have previously showcased Mr. Li's case (click on the blue text to view "Preventing Recurrence and Metastasis After Lung Cancer Surgery"). In the new year, will he continue to maintain his "excellent performance"

Fortunately, Mr. Li's friend, Mr. Wang, has been diagnosed with advanced bile duct cancer. Mr. Wang has experienced a recurrence of bile duct cancer one year after surgery, and his liver cancer has also recurred repeatedly. However, after receiving NKT cell therapy from Professor Zhang Minghui of Tsinghua University, the tumor development was successfully suppressed, and there has been no recurrence or metastasis for over five years! Therefore, Mr. Li made a prompt decision to undergo NKT cell therapy immediately after surgery and has continued to do so ever since. After understanding Mr. Li's condition, our team formulated a treatment plan of one course per two months, with the main goal of preventing recurrence and metastasis. The efficacy evaluation indicator is progression-free survival (PFS). As of June 2021, after 26 consecutive courses of systematic treatment and regular follow-up with lung CT scans, head and abdominal magnetic resonance imaging, the patient has shown no clear signs of recurrence or metastasis for 53 consecutive months.

In this follow-up, Mr. Li remains in good health as usual, with stable weight, good sleep and appetite, and continues with his daily work. His quality of life score this time is 89, an improvement from the previous score of 83.

NKT Classic Case Review

Click on the image

to view